Posted: 12:00 a.m. Friday, January 19, 2018
But pot industry uncertainty has increased as Trump administration tightens federal marijuana policies.
Pediatric neurologist Scott Perry is optimistic he’ll soon be able to answer some questions that have been on the minds of his epilepsy patients and their families.
“I don’t think I go a day without the majority of patients actually asking about it,” Perry said. “If I don’t mention it myself, they’ll say, ‘What’s going on with it? What about it?’”
The “it” is cannabidiol, or CBD, an oil extracted from medical cannabis plants. Unlike conventional marijuana, it doesn’t produce a high, but it has shown promise in treating a variety of ailments, including epileptic seizures.
A form of cannabidiol tailored to treat seizures is on the cusp of becoming available in Texas, but only for a small segment of people suffering from a rare form of epilepsy — and only if directed by a doctor. Two of the three CBD dispensaries granted licenses under the state’s narrow 2015 medical cannabis law, called the Compassionate Use Act, are either in the process of arranging initial deliveries of their products or expect to be ready to do so soon.
Cansortium Texas, based in Schulenburg, has its CBD oil — which it has branded as “Zeltor” — ready to dispense, while Compassionate Cultivation, which is in Manchaca, is harvesting its first crop of medical cannabis this week and expects to have refined products available by early February.
The pending start of CBD sales